Isoform‐selective phosphoinositide 3‐kinase inhibitors induce apoptosis in chronic lymphocytic leukaemia cells
- 9 June 2010
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 150 (1) , 108-110
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Functional Whole-genome Analysis Identifies Polo-like Kinase 2 and Poliovirus Receptor as Essential for Neuronal Differentiation Upstream of the Negative Regulator αB-crystallinJournal of Biological Chemistry, 2009
- Molecular and cellular mechanisms of CLL: novel therapeutic approachesNature Reviews Clinical Oncology, 2009
- Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell–mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approachBlood, 2009
- The immunodeficiency of chronic lymphocytic leukaemiaBritish Medical Bulletin, 2008
- Targeting phosphoinositide 3-kinase—Moving towards therapyBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- Key role of the p110δ isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110δ function in B cellsBlood, 2006
- PI 3-kinase p110β: a new target for antithrombotic therapyNature Medicine, 2005
- Involvement of protein kinase C and phosphatidylinositol 3–kinase pathways in the survival of B-cell chronic lymphocytic leukemia cellsBlood, 2002